Global Information
회사소개 | 문의 | 비교리스트

세계의 코로나바이러스 감염증(COVID-19) 치료 시장 : 치료 유형별, 지역별 시장 규모와 예측(2020-2026년)

Coronavirus (COVID-19)Treatment Market Global Market Size Study, Estimates & Forecasts: 2019-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2020년 05월 상품 코드 935961
페이지 정보 영문
가격
US $ 4,950 ₩ 5,659,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,146,000 Printable PDF (Enterprise License)


세계의 코로나바이러스 감염증(COVID-19) 치료 시장 : 치료 유형별, 지역별 시장 규모와 예측(2020-2026년) Coronavirus (COVID-19)Treatment Market Global Market Size Study, Estimates & Forecasts: 2019-2027
발행일 : 2020년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신종 코로나바이러스 감염증(COVID-19) 치료 시장을 조사했으며, 팬데믹의 영향을 포함한 시장 역학, 업계 분석, 치료 유형별, 지역별 분석, 경쟁 구도와 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 개요

제2장 시장의 정의와 범위

제3장 시장 역학

  • 영향 분석(2018-2026년)
    • 시장 성장요인
    • 시장이 해결해야 할 과제
    • 시장 기회

제4장 업계 분석

  • Porter's Five Forces 모델
    • 공급업체의 교섭력
    • 바이어의 교섭력
    • 신규 참여 세력의 위협
    • 대체품의 위협
    • 기업간 경쟁
    • Porter's Five Forces 모델에 대한 미래적 접근
  • PEST 분석
    • 정치적
    • 경제적
    • 사회적
    • 기술적
  • 투자 채택 모델
  • 애널리스트의 제안과 결론

제5장 치료 유형별 시장 분석

  • 시장 스냅숏
  • 시장 실적과 성장성 분석
  • 시장 예측
  • 하위 부문 분석
    • 치료제
    • 예방 백신

제6장 지역 시장 분석

  • 각 지역 시장 스냅숏
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타

제7장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Moderna Therapeutics
    • Inovio Pharmaceuticals, Inc.
    • Clover Biopharmaceuticals
    • ExpreS2ion Biotechnologies ApS
    • CanSino Biologics, Inc.
    • Greffex Inc.
    • Altimmune
    • Janssen Pharmaceuticals
    • Ascletis Pharma Inc.
    • Bravovax

제8장 조사 프로세스

KSA 20.06.10

LIST OF TABLES

  • TABLE 1. List of secondary sources, used in the study of global Coronavirus (COVID-19) Treatment market
  • TABLE 2. List of primary sources, used in the study of global Coronavirus (COVID-19) Treatment market
  • TABLE 3. Global Coronavirus (COVID-19) Treatment market, report scope
  • TABLE 4. Years considered for the study
  • TABLE 5. Exchange rates considered
  • TABLE 6. Global Coronavirus (COVID-19) Treatment market estimates & forecasts by region 2019-2027 (USD Billion)
  • TABLE 7. Global Coronavirus (COVID-19) Treatment market estimates & forecasts by Treatment Type 2019-2027 (USD Billion)
  • TABLE 8. Global Coronavirus (COVID-19) Treatment market by segment, estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 9. Global Coronavirus (COVID-19) Treatment market by region, estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 10. Global Coronavirus (COVID-19) Treatment market by segment, estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 11. Global Coronavirus (COVID-19) Treatment market by region, estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 12. U.S. Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD BILLION)
  • TABLE 13. U.S. Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD BILLION)
  • TABLE 14. U.S. Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD BILLION)
  • TABLE 15. CANADA Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD BILLION)
  • TABLE 16. CANADA Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD BILLION)
  • TABLE 17. Canada Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD BILLION)
  • TABLE 18. UK Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD BILLION)
  • TABLE 19. UK Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD BILLION)
  • TABLE 20. UK Coronavirus (COVID-19) Treatment Market Estimates & Forecasts by Segment 2019-2027 (USD BILLION)
  • TABLE 21. Germany Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 22. Germany Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 23. Germany Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 24. Roe Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 25. Roe Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 26. Roe Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 27. China Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 28. China Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 29. China Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 30. India Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 31. India Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 32. India Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 33. Japan Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 34. Japan Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 35. Japan Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 36. ROAPAC Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 37. ROAPAC Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 38. ROAPAC Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 39. Brazil Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 40. Brazil Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 41. Brazil Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 42. Mexico Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 43. Mexico Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 44. Mexico Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 45. ROLA Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 46. ROLA Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 47. ROLA Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 48. ROW Coronavirus (COVID-19) Treatment market estimates & forecasts, 2019-2027 (USD Billion)
  • TABLE 49. ROW Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)
  • TABLE 50. ROW Coronavirus (COVID-19) Treatment market estimates & forecasts by segment 2019-2027 (USD Billion)

LIST OF FIGURES

  • FIG 1. Global Coronavirus (COVID-19) Treatment market, research methodology
  • FIG 2. Global Coronavirus (COVID-19) Treatment market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Coronavirus (COVID-19) Treatment market, key trends 2019
  • FIG 5. Global Coronavirus (COVID-19) Treatment market, growth prospects 2020-2026
  • FIG 6. Global Coronavirus (COVID-19) Treatment market, porters 5 force model
  • FIG 7. Global Coronavirus (COVID-19) Treatment market, pest analysis
  • FIG 8. Global Coronavirus (COVID-19) Treatment market, value chain analysis
  • FIG 9. Global Coronavirus (COVID-19) Treatment market by segment, 2016 & 2026 (USD Billion)
  • FIG 10. Global Coronavirus (COVID-19) Treatment market by segment, 2016 & 2026 (USD Billion)
  • FIG 11. Global Coronavirus (COVID-19) Treatment market, regional snapshot 2016 & 2026
  • FIG 12. North America Coronavirus (COVID-19) Treatment market 2016 & 2026 (USD Billion)
  • FIG 13. Europe Coronavirus (COVID-19) Treatment market 2016 & 2026 (USD Billion)
  • FIG 14. Asia pacific Coronavirus (COVID-19) Treatment market 2016 & 2026 (USD Billion)
  • FIG 15. Latin America Coronavirus (COVID-19) Treatment market 2016 & 2026 (USD Billion)
  • FIG 16. Global Coronavirus (COVID-19) Treatment market, company market share analysis (2019)

Global Coronavirus (COVID-19) Treatment Market is valued approximately USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. The COVID-19 outbreak triggered owing to Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), which is affecting millions of citizens worldwide. According to the World Health Organization, SARS-CoV-2 has spread to over 209 countries and territories with over as of 20th April 2020, 2,314,621 confirmed coronavirus cases were recorded with 157,847 deaths globally. The sudden epidemic of this extremely contagion disease has the increased the revenue of the pharmaceutical industry and propelling the industry to perform more than their unique production capacity. The major pharmaceutical companies are highly involved in the R&D activities for developing preventive interventions and therapeutic medicine. Exponentially growing incidents worldwide necessitating short- and long-term respiratory support and multiple collaborations for the development of medications for COVID-19 with ongoing clinical trials are some of the key factors likely to drive the market over the forecast period. For instance, the United States National Institute of Health (NIH) has initiated COVID-19 vaccine trial on 16 March 2020. Similarly, on February 2020, Gilead Sciences is assessing a drug, remdesivir, a nucleoside analog presently in phase 3 clinical trial for the treatment of COVID-19.

The regional analysis of global Coronavirus (COVID-19) Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to owing to high number of COVID-19 cases in the United States which require rapid number of testing in the near future to contain the spread of disease in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as owing to large scale of population base in the countries such as India and China, rapid growth in number of coronavirus infected cases would create lucrative growth prospects for the Coronavirus (COVID-19) Treatment market across Asia-Pacific region.

Major market player included in this report are:

  • Moderna Therapeutics
  • Inovio Pharmaceuticals, Inc.
  • Clover Biopharmaceuticals
  • ExpreS2ion Biotechnologies ApS
  • CanSino Biologics, Inc.
  • Greffex Inc.
  • Altimmune
  • Janssen Pharmaceuticals
  • Ascletis Pharma Inc.
  • Bravovax,

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

  • Disease treatment drugs
  • Preventive vaccines.

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
    • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2026

Target Audience of the Global Coronavirus (COVID-19) Treatment Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Coronavirus (COVID-19) Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Coronavirus (COVID-19) Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Coronavirus (COVID-19) Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Coronavirus (COVID-19) Treatment Market Dynamics

  • 3.1. Coronavirus (COVID-19) Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Coronavirus (COVID-19) Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Coronavirus (COVID-19) Treatment Market, by Treatment Type

  • 5.1. Market Snapshot
  • 5.2. Global Coronavirus (COVID-19) Treatment Market by Treatment Type, Performance - Potential Analysis
  • 5.3. Global Coronavirus (COVID-19) Treatment Market Estimates & Forecasts by Treatment Type 2019-2027 (USD Billion)
  • 5.4. Coronavirus (COVID-19) Treatment Market, Sub Segment Analysis
    • 5.4.1. Disease treatment drugs
    • 5.4.2. Preventive vaccines

Chapter 6. Global Coronavirus (COVID-19) Treatment Market, Regional Analysis

  • 6.1. Coronavirus (COVID-19) Treatment Market, Regional Market Snapshot
  • 6.2. North America Coronavirus (COVID-19) Treatment Market
    • 6.2.1. U.S. Coronavirus (COVID-19) Treatment Market
      • 6.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2027
    • 6.2.2. Canada Coronavirus (COVID-19) Treatment Market
  • 6.3. Europe Coronavirus (COVID-19) Treatment Market Snapshot
    • 6.3.1. U.K. Coronavirus (COVID-19) Treatment Market
    • 6.3.2. Germany Coronavirus (COVID-19) Treatment Market
    • 6.3.3. Rest of Europe Coronavirus (COVID-19) Treatment Market
  • 6.4. Asia-Pacific Coronavirus (COVID-19) Treatment Market Snapshot
    • 6.4.1. China Coronavirus (COVID-19) Treatment Market
    • 6.4.2. India Coronavirus (COVID-19) Treatment Market
    • 6.4.3. Japan Coronavirus (COVID-19) Treatment Market
    • 6.4.4. Rest of Asia Pacific Coronavirus (COVID-19) Treatment Market
  • 6.5. Latin America Coronavirus (COVID-19) Treatment Market Snapshot
    • 6.5.1. Brazil Coronavirus (COVID-19) Treatment Market
    • 6.5.2. Mexico Coronavirus (COVID-19) Treatment Market
  • 6.6. Rest of The World Coronavirus (COVID-19) Treatment Market

Chapter 7. Competitive Intelligence

  • 7.1. Top Market Strategies
  • 7.2. Company Profiles
    • 7.2.1. Moderna Therapeutics
      • 7.2.1.1. Key Information
      • 7.2.1.2. Overview
      • 7.2.1.3. Financial (Subject to Data Availability)
      • 7.2.1.4. Product Summary
      • 7.2.1.5. Recent Developments
    • 7.2.2. Inovio Pharmaceuticals, Inc.
    • 7.2.3. Clover Biopharmaceuticals
    • 7.2.4. ExpreS2ion Biotechnologies ApS
    • 7.2.5. CanSino Biologics, Inc.
    • 7.2.6. Greffex Inc.
    • 7.2.7. Altimmune
    • 7.2.8. Janssen Pharmaceuticals
    • 7.2.9. Ascletis Pharma Inc.
    • 7.2.10. Bravovax

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
  • 8.3. Research Assumption
Back to Top
전화 문의
F A Q